These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 31230432)

  • 1. Four Novel Synthetic Tryptamine Analogs Induce Head-Twitch Responses and Increase 5-HTR2a in the Prefrontal Cortex in Mice.
    Abiero A; Ryu IS; Botanas CJ; Custodio RJP; Sayson LV; Kim M; Lee HJ; Kim HJ; Seo JW; Cho MC; Lee KW; Yoo SY; Jang CG; Lee YS; Cheong JH
    Biomol Ther (Seoul); 2020 Jan; 28(1):83-91. PubMed ID: 31230432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 5-Methoxy-α-methyltryptamine (5-MeO-AMT), a tryptamine derivative, induces head-twitch responses in mice through the activation of serotonin receptor 2a in the prefrontal cortex.
    Abiero A; Botanas CJ; Sayson LV; Custodio RJ; de la Peña JB; Kim M; Lee HJ; Seo JW; Ryu IS; Chang CM; Yang JS; Lee YS; Jang CG; Kim HJ; Cheong JH
    Behav Brain Res; 2019 Feb; 359():828-835. PubMed ID: 30053461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological analysis of the variation in behavioural responses to tryptamine in five strains of mice.
    Yamada J; Sugimoto Y; Horisaka K
    Eur J Pharmacol; 1987 Aug; 140(3):323-30. PubMed ID: 3653248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel synthetic cathinone, 2-(methylamino)-1-(naphthalen-2-yl) propan-1-one (BMAPN), produced rewarding effects and altered striatal dopamine-related gene expression in mice.
    Botanas CJ; Yoon SS; de la Peña JB; Dela Peña IJ; Kim M; Woo T; Seo JW; Jang CG; Park KT; Lee YH; Lee YS; Kim HJ; Cheong JH
    Behav Brain Res; 2017 Jan; 317():494-501. PubMed ID: 27737791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 25B-NBOMe, a novel N-2-methoxybenzyl-phenethylamine (NBOMe) derivative, may induce rewarding and reinforcing effects via a dopaminergic mechanism: Evidence of abuse potential.
    Custodio RJP; Sayson LV; Botanas CJ; Abiero A; You KY; Kim M; Lee HJ; Yoo SY; Lee KW; Lee YS; Seo JW; Ryu IS; Kim HJ; Cheong JH
    Addict Biol; 2020 Nov; 25(6):e12850. PubMed ID: 31749223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 1-Phenylcyclohexan-1-amine hydrochloride (PCA HCl) alters mesolimbic dopamine system accompanied by neuroplastic changes: A neuropsychopharmacological evaluation in rodents.
    Abiero A; Perez Custodio RJ; Botanas CJ; Ortiz DM; Sayson LV; Kim M; Lee HJ; Yoon S; Lee YS; Cheong JH; Kim HJ
    Neurochem Int; 2021 Mar; 144():104962. PubMed ID: 33460722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The novel methoxetamine analogs N-ethylnorketamine hydrochloride (NENK), 2-MeO-N-ethylketamine hydrochloride (2-MeO-NEK), and 4-MeO-N-ethylketamine hydrochloride (4-MeO-NEK) elicit rapid antidepressant effects via activation of AMPA and 5-HT
    Sayson LV; Botanas CJ; Custodio RJP; Abiero A; Kim M; Lee HJ; Kim HJ; Yoo SY; Lee KW; Ryu HW; Acharya S; Kim KM; Lee YS; Cheong JH
    Psychopharmacology (Berl); 2019 Jul; 236(7):2201-2210. PubMed ID: 30891619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tolerance and cross-tolerance to head twitch behavior elicited by phenethylamine- and tryptamine-derived hallucinogens in mice.
    Smith DA; Bailey JM; Williams D; Fantegrossi WE
    J Pharmacol Exp Ther; 2014 Dec; 351(3):485-91. PubMed ID: 25271256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The abuse potential of two novel synthetic cathinones with modification on the alpha-carbon position, 2-cyclohexyl-2-(methylamino)-1-phenylethanone (MACHP) and 2-(methylamino)-1-phenyloctan-1-one (MAOP), and their effects on dopaminergic activity.
    Botanas CJ; Yoon SS; de la Peña JB; Dela Peña IJ; Kim M; Woo T; Seo JW; Jang CG; Park KT; Lee YH; Lee YS; Kim HJ; Cheong JH
    Pharmacol Biochem Behav; 2017 Feb; 153():160-167. PubMed ID: 28063946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the Abuse Potential of Novel Amphetamine Derivatives with Modifications on the Amine (NBNA) and Phenyl (EDA, PMEA, 2-APN) Sites.
    Custodio RJP; Botanas CJ; Yoon SS; Peña JB; Peña IJD; Kim M; Woo T; Seo JW; Jang CG; Kwon YH; Kim NY; Lee YS; Kim HJ; Cheong JH
    Biomol Ther (Seoul); 2017 Nov; 25(6):578-585. PubMed ID: 29081089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Receptor binding profiles and behavioral pharmacology of ring-substituted N,N-diallyltryptamine analogs.
    Klein LM; Cozzi NV; Daley PF; Brandt SD; Halberstadt AL
    Neuropharmacology; 2018 Nov; 142():231-239. PubMed ID: 29499272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation between the potency of hallucinogens in the mouse head-twitch response assay and their behavioral and subjective effects in other species.
    Halberstadt AL; Chatha M; Klein AK; Wallach J; Brandt SD
    Neuropharmacology; 2020 May; 167():107933. PubMed ID: 31917152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monoamine oxidase inhibitors in South American hallucinogenic plants Part 2: Constituents of orally-active Myristicaceous hallucinogens.
    McKenna DJ; Towers GH; Abbott FS
    J Ethnopharmacol; 1984 Nov; 12(2):179-211. PubMed ID: 6521493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new synthetic drug 5-(2-aminopropyl)indole (5-IT) induces rewarding effects and increases dopamine D1 receptor and dopamine transporter mRNA levels.
    Botanas CJ; Yoon SS; de la Peña JB; Dela Peña IJ; Kim M; Custodio RJ; Woo T; Seo JW; Jang CG; Yang JS; Yoon YM; Lee YS; Kim HJ; Cheong JH
    Behav Brain Res; 2018 Apr; 341():122-128. PubMed ID: 29288746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. alpha-Methylated tryptamine derivatives induce a 5-HT receptor-mediated head-twitch response in mice.
    Tadano T; Neda M; Hozumi M; Yonezawa A; Arai Y; Fujita T; Kinemuchi H; Kisara K
    Neuropharmacology; 1995 Feb; 34(2):229-34. PubMed ID: 7617148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic treatment with a metabotropic mGlu2/3 receptor agonist diminishes behavioral response to a phenethylamine hallucinogen.
    Halberstadt AL; van der Zee JVF; Chatha M; Geyer MA; Powell SB
    Psychopharmacology (Berl); 2019 Feb; 236(2):821-830. PubMed ID: 30448990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of the Abuse Liability of Synthetic Cannabinoid Agonists JWH-030, JWH-175, and JWH-176.
    Tampus R; Yoon SS; de la Peña JB; Botanas CJ; Kim HJ; Seo JW; Jeong EJ; Jang CG; Cheong JH
    Biomol Ther (Seoul); 2015 Nov; 23(6):590-6. PubMed ID: 26535085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitory effects of tryptamine on tolbutamide-induced hypoglycemia in mice: mediation by 5-HT receptors.
    Sugimoto Y; Yamada J; Kimura I; Watanabe Y; Horisaka K
    Neurochem Res; 1994 Jan; 19(1):19-22. PubMed ID: 8139757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of age and of chronic antidepressant treatment on [3H]tryptamine and [3H]dihydroalprenolol binding to rat cortical membranes.
    Mousseau DD; McManus DJ; Baker GB; Juorio AV; Dewhurst WG; Greenshaw AJ
    Cell Mol Neurobiol; 1993 Feb; 13(1):3-13. PubMed ID: 8384528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional study of rat 5-HT2A receptors using antisense oligonucleotides.
    Van Oekelen D; Megens A; Meert T; Luyten WH; Leysen JE
    J Neurochem; 2003 Jun; 85(5):1087-100. PubMed ID: 12753068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.